Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn in disseminated intravascular coagulation associated with severe sepsis
2006-002873-35Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of antithrombin III in disseminated intravascular coagulation (DIC) and sepsis, sponsored by LEO Pharma. Primary endpoint: Composite response at day 28. Started Feb 2007; status: completed.
02
Drugs
antithrombin III
03
Conditions
disseminated intravascular coagulation (DIC)sepsis
Beyond the preview
Go deeper on 2006-002873-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002873-35.